Form 4: ClearPoint Neuro CFO D'Alessandro Reports Stock Acquisition Through Employee Stock Purchase Plan

ClearPoint Neuro's CFO, Danilo D'Alessandro, reports acquiring 1,913 shares of common stock through the company's Employee Stock Purchase Plan (ESPP) at a price of $4.58 per share.

Summary

• Danilo D'Alessandro, the Chief Financial Officer of ClearPoint Neuro, Inc., filed a Form 4 with the SEC.
• The filing reports a transaction on June 28, 2024, where D'Alessandro acquired 1,913 shares of ClearPoint Neuro common stock.
• The acquisition was made through the company's Employee Stock Purchase Plan (ESPP).
• The price per share was $4.58.
• Following the transaction, D'Alessandro beneficially owns 50,683 shares of ClearPoint Neuro common stock.
• The shares were purchased at 85% of the fair market value on either the first day or last day of the purchase period (January 1, 2024 through June 30, 2024).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to an employee benefit program. The CFO's participation is a mildly positive signal, but not significantly impactful.

Positives

• The CFO's participation in the ESPP could be seen as a positive signal, indicating confidence in the company's future.

Industry Context

Form 4 filings are routine disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. It provides transparency to the market.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals insider confidence.

Key Dates